arXiv Paper Links Mammography Gaps to Emergency Dept. Costs

A new preprint posted on arXiv models how disruptions in mammography screening cascade into higher emergency-department spending for breast cancer. The paper, which has not yet been peer-reviewed, estimates that even short interruptions in screening schedules produce measurable increases in later-stage diagnoses and emergency visits, with associated costs running into millions for a typical health system.

Researchers built their simulation around standard screening intervals and empirical cancer-progression data. When screening stops – whether from a pandemic, policy change, or capacity constraints – the model shows a shift in the stage at which cancers are first detected. More cases arrive in emergency rooms rather than through routine imaging. That shift raises per-patient treatment costs and strains hospital resources.

For investors watching the diagnostic-imaging and hospital-payer sectors, the paper adds a concrete data point to a long-running debate. The mechanism is straightforward: screening detects early-stage, highly treatable cancers. Without it, those same cancers progress, become symptomatic, and eventually require urgent care that is more invasive and more expensive. The model quantifies the trade-off in emergency department visits per thousand women screened versus unscreened.